Building Resilience and Vital Equity (BRAVE) - Increasing COVID-19 Testing in American Indians

建立韧性和重要公平 (BRAVE) - 增加美洲印第安人的 COVID-19 检测

基本信息

  • 批准号:
    10258335
  • 负责人:
  • 金额:
    $ 139.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-09-26 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Abstract The COVID19 pandemic continues to hit hardest on underserved communities including American Indians (AI)/Alaska Natives (AN). Diseases with significant health disparities and social determinants of health are major risk factors and define COVID19 related disparities among AI/AN. Increased testing and upcoming adherence to vaccination recommendations are two important strategies to manage COVID19 and mitigate the impact of the virus on marginalized communities. Mounting evidence indicates that underserved communities are less likely to actively participate in mass testing and immunization recommendations due to poverty, access, inadequate information, logistics and issues surrounding fear, stigma and trust. North Carolina (NC) has the largest AI population east of the Mississippi River and the sixth largest AI population in the nation with more than half living in rural underserved counties of Robeson, Scotland, Hoke and Cumberland. This proposal is a partnership between two community engaged academic institutions (North Carolina Central University - NCCU and University of North Carolina at Pembroke-UNCP) and a major community partner – The Lumbee Tribe of North Carolina (LTNC) with 62,500 members. We hypothesize that a bidirectional community- engaged approach to understand the social ethical and behavioral implications (SEBI) combined with focused interventions to address the barriers will increase testing and mitigate the consequences of COVID-19 in AI communities of NC. The specific aims of the proposal are (1) To understand the barriers and social implications of COVID19 testing among American Indians by designing and implementing culturally sensitive survey tools and intervention materials. (2) Implement BRAVE outreach and testing interventions to increase testing in American Indian community and (3) Data analysis, evaluation and data sharing. BRAVE is a bold community-engaged initiative to increase testing by addressing disparities and building resiliency to change the narrative from struggle to strength in AI community as we fight this unfortunate public health emergency.
摘要 COVID 19大流行继续对包括美洲印第安人在内的服务不足社区造成最严重的打击 (AI)阿拉斯加原住民(Alaska Natives)具有重大健康差异的疾病和健康的社会决定因素是 主要风险因素,并定义AI/AN之间的COVID 19相关差异。增加测试和即将到来的 遵守疫苗接种建议是管理COVID 19和减轻 病毒对边缘化社区的影响。越来越多的证据表明, 由于贫困,不太可能积极参与大规模检测和免疫建议, 接触、信息不足、后勤以及围绕恐惧、耻辱和信任的问题。北卡罗来纳州(NC) 拥有密西西比河以东最大的人工智能人口和全国第六大人工智能人口, 超过一半的人生活在罗伯逊、苏格兰、霍克和坎伯兰等服务水平低下的农村县。这 一项提案是两个社区参与的学术机构(北卡罗来纳州中央)之间的伙伴关系 大学- NCCU和北卡罗来纳州彭布罗克大学-UNCP)和一个主要的社区合作伙伴- 北卡罗来纳州的伦比部落(LTNC),有62,500名成员。我们假设一个双向社区- 参与的方法来理解社会道德和行为的影响(SEBI)结合重点 解决这些障碍的干预措施将增加测试并减轻COVID-19在人工智能中的后果 NC社区该提案的具体目标是(1)了解障碍和社会 通过设计和实施文化敏感的COVID 19测试在美洲印第安人中的影响 调查工具和干预材料。(2)实施BRAVE外展和测试干预措施, (3)数据分析、评估和数据共享。勇敢是一种勇敢 社区参与的倡议,通过解决差异和建立弹性来增加测试,以改变 在我们与这场不幸的公共卫生紧急事件作斗争时,人工智能社区从斗争到力量的叙述。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DEEPAK KUMAR其他文献

DEEPAK KUMAR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DEEPAK KUMAR', 18)}}的其他基金

NCCU RCMI Practice Based Equity Research Network (PBERN)
NCCU RCMI 基于实践的股票研究网络 (PBERN)
  • 批准号:
    10644944
  • 财政年份:
    2022
  • 资助金额:
    $ 139.07万
  • 项目类别:
Molecular Determinants of Social Factors in Prostate Cancer
前列腺癌社会因素的分子决定因素
  • 批准号:
    10369300
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
RCMI Center for Health Disparities Research
RCMI 健康差异研究中心
  • 批准号:
    9750521
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
NCCU-RCMI Partnership with a Practice-Based Clinical Research Network
NCCU-RCMI 与基于实践的临床研究网络合作
  • 批准号:
    10475461
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
RCHDR Administrative Core
RCHDR 行政核心
  • 批准号:
    10204731
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10708075
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
Molecular Determinants of Social Factors in Prostate Cancer
前列腺癌社会因素的分子决定因素
  • 批准号:
    9794453
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
Investigator Development Core (IDC)
研究者开发核心 (IDC)
  • 批准号:
    9977711
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
Molecular Determinants of Social Factors in Prostate Cancer
前列腺癌社会因素的分子决定因素
  • 批准号:
    10408227
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:
RCMI Center for Health Disparities Research
RCMI 健康差异研究中心
  • 批准号:
    10204728
  • 财政年份:
    2017
  • 资助金额:
    $ 139.07万
  • 项目类别:

相似海外基金

I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
    Standard Grant
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
    Operating Grants
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
    Grant for R&D
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 139.07万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了